WHITEPAPER

Delivering on the Promise of Automation in Pharmacovigilance

Let's Connect

By clicking ‘Submit’ button, you are agreeing to opt-in to communications from ArisGlobal and use of the above information for ArisGlobal products, news & updates.

Note: You can unsubscribe to email communication from ArisGlobal any time.

As the volume of global post-marketing adverse event (AE) reports continues to rise at rate of 15% per year, it has become difficult for pharmacovigilance teams to handle an increased work-load with fixed resources and tight budgets.

Unsurprisingly, automation has become a widely discussed topic in the industry, with many organizations actively pursuing methods of streamlining case processing through automation technologies.

To prove the potential that automation has in transforming pharmacovigilance, ArisGlobal conducted a time study across five key use cases featuring its all-new LifeSphere MultiVigilance safety system.

The results from the time study were clear, and show that automation can lead to significant efficiency gains, while also providing helpful measurement benchmarks to plot continuous improvement over time.

 

Download the whitepaper to learn more.